{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:15:21Z","timestamp":1762917321182},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T00:00:00Z","timestamp":1292284800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0014330","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T20:43:33Z","timestamp":1292359413000},"page":"e14330","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories"],"prefix":"10.1371","volume":"5","author":[{"given":"Dilbinder K.","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunda","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail L.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sambor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald K.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Kopycinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Birungi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Tarragona-Fiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Randles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew Raxworthy","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloysius","family":"Ssemaganda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Self","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Koup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine H.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1126\/science.1086916","article-title":"Medicine. The need for a global HIV vaccine enterprise.","volume":"300","author":"RD Klausner","year":"2003","journal-title":"Science"},{"key":"ref2","first-page":"93","article-title":"The global HIV vaccine enterprise.","volume":"8","author":"J Esparza","year":"2005","journal-title":"Int Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1126\/science.1086916","article-title":"The Need for a Global HIV Vaccine Enterprise.","volume":"300","author":"RD Klausner","year":"2003","journal-title":"Science"},{"key":"ref4","first-page":"1","article-title":"Good Clinical Laboratory Practice (GCLP). A Quality System for Laboratories which undertake the Analyses of Samples from Clinical Trials.","author":"T Stiles","year":"2003","journal-title":"BARQA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/367702","article-title":"Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.","volume":"187","author":"ND Russell","year":"2003","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-1759(83)90308-3","article-title":"A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.","volume":"65","author":"CC Czerkinsky","year":"1983","journal-title":"J Immunol Methods"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cncr.21956","article-title":"Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.","volume":"107","author":"BI Rini","year":"2006","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/JVI.80.10.4717-4728.2006","article-title":"Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.","volume":"80","author":"N Goonetilleke","year":"2006","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nprot.2009.7","article-title":"The role of IFN-gamma Elispot assay in HIV vaccine research.","volume":"4","author":"H Streeck","year":"2009","journal-title":"Nat Protoc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1002\/eji.200939434","article-title":"Multiple functions of human T cells generated by experimental malaria challenge.","volume":"39","author":"SM Todryk","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/jmv.10318","article-title":"Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization.","volume":"70","author":"JG Smith","year":"2003","journal-title":"J Med Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/aid.2005.21.68","article-title":"Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.","volume":"21","author":"JH Cox","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-007-0380-6","article-title":"Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC\/SVI).","volume":"57","author":"S Janetzki","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/CVI.00326-08","article-title":"Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents.","volume":"16","author":"MJ Boaz","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/QAI.0b013e3180377b5b","article-title":"Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot <underline>assay<\/underline>.","volume":"May 1;45","author":"S Dubey","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jim.2007.02.003","article-title":"Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.","volume":"322","author":"M Bull","year":"2007","journal-title":"J Immunol Methods"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.","volume":"260","author":"J Currier","year":"2002","journal-title":"J Immunol Methods"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jim.2006.07.015","article-title":"Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials.","volume":"315","author":"Z Moodie","year":"2006","journal-title":"J Immunol Methods"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/sim.1781","article-title":"Simple improved confidence intervals for comparing matched proportions.","volume":"24","author":"A Agresti","year":"2005","journal-title":"Stat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility.","volume":"45","author":"LI Lin","year":"1989","journal-title":"Biometrics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-1759(97)00019-7","article-title":"The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumour necrosis factor \u03b1 spots in response to peptide antigens.","volume":"203","author":"W Herr","year":"1997","journal-title":"J Immunol Methods"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2009.02.007","article-title":"Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses.","volume":"344","author":"CA Almeida","year":"2009","journal-title":"J Immunol Methods"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/aid.2006.0129","article-title":"Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC.","volume":"23","author":"LS Kierstead","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2009.09.007","article-title":"\u201cMIATA\u201d-minimal information about T cell assays.","volume":"31","author":"S Janetzki","year":"2009","journal-title":"Immunity"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0014330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:43:24Z","timestamp":1589010204000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0014330"}},"subtitle":[],"editor":[{"given":"Rupert","family":"Kaul","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,14]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0014330","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,14]]}}}